BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 6235142)

  • 21. Comparative studies on acetazolamide teratogenesis in pregnant rats, rabbits, and rhesus monkeys.
    Scott WJ; Hirsch KS; DeSesso JM; Wilson JG
    Teratology; 1981 Aug; 24(1):37-42. PubMed ID: 6795737
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of co-administration of retinoids on rat embryo development in vitro.
    Ritchie HE; Brown-Woodman PD; Korabelnikoff A
    Birth Defects Res A Clin Mol Teratol; 2003 Jun; 67(6):444-51. PubMed ID: 12962289
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vivo phenytoin-initiated oxidative damage to proteins and lipids in murine maternal hepatic and embryonic tissue organelles: potential molecular targets of chemical teratogenesis.
    Liu L; Wells PG
    Toxicol Appl Pharmacol; 1994 Apr; 125(2):247-55. PubMed ID: 8171432
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of oxygenation in embryotoxic mechanisms of three bioreducible agents.
    Barber CV; Fantel AG
    Teratology; 1993 Mar; 47(3):209-23. PubMed ID: 8475464
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Combined prenatal toxicity of 6-mercaptopurine riboside and hydroxyurea in mice.
    Platzek T; Schwabe R
    Teratog Carcinog Mutagen; 1999; 19(3):223-32. PubMed ID: 10379846
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Transient inhibition of DNA synthesis by methotrexate, in the rat embryo and foetus.
    Berry CL
    J Embryol Exp Morphol; 1971 Dec; 26(3):469-74. PubMed ID: 5316995
    [No Abstract]   [Full Text] [Related]  

  • 27. Inhibition of ribonucleotide reductase by a new class of isoindole derivatives: drug synergism with cytarabine (Ara-C) and induction of cellular apoptosis.
    Nandy P; Lien EJ; Avramis VI
    Anticancer Res; 1999; 19(3A):1625-33. PubMed ID: 10470093
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Coteratogenic effects of caffeine.
    Sivak A
    Regul Toxicol Pharmacol; 1994 Feb; 19(1):1-13. PubMed ID: 8159809
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Variability in human embryonic development and its implications for the susceptibility to environmental teratogenesis.
    Shiota K
    Birth Defects Res A Clin Mol Teratol; 2009 Aug; 85(8):661-6. PubMed ID: 19606457
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparative studies of repair using inhibitors.
    Johnson RT; Collins AR; Elliott GC; Squires S
    Nucleic Acids Symp Ser; 1984; (13):255-77. PubMed ID: 6387629
    [No Abstract]   [Full Text] [Related]  

  • 31. Critical period for a teratogenic VLA-4 antagonist: Developmental effects and comparison of embryo drug concentrations of teratogenic and non-teratogenic VLA-4 antagonists.
    Crofts F; Rohatagi S; Pino M; DeLise B; Zhang J; Nguyen M; Guittin P; Barbellion S; Brunel P; Hofmann T; Schmidt J; Wong M; Lockey P; Lerman S; Clark R
    Birth Defects Res B Dev Reprod Toxicol; 2004 Apr; 71(2):69-79. PubMed ID: 15098200
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Response to the letter of Hanley et al. ([1999] Teratology 59:323-324), concerning the article by Roy et al. ([1998] Teratology 58:62-68).
    Slotkin TA; Andrews JE
    Teratology; 1999 Oct; 60(4):177-8. PubMed ID: 10508970
    [No Abstract]   [Full Text] [Related]  

  • 33. [Embryotoxic and teratogenic effect of Pharmachem tetramisole].
    Stoianov K; Todorov S
    Vet Med Nauki; 1982; 19(7):61-5. PubMed ID: 7157663
    [TBL] [Abstract][Full Text] [Related]  

  • 34. DNA synthesis inhibition, cytotoxicity and their relationship to teratogenesis following administration of a nicotinamide antagonist, aminothiadiazole, to pregnant rats.
    Scott WJ; Ritter EJ; Wilson JG
    J Embryol Exp Morphol; 1973 Aug; 30(1):257-66. PubMed ID: 4269736
    [No Abstract]   [Full Text] [Related]  

  • 35. [Teratogenic effects of 9-hydroxy-ellipticine in mouse embryo].
    Cros S; Raynaud A
    C R Seances Acad Sci III; 1982 Oct; 295(7):465-70. PubMed ID: 6819062
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Amelioration of teratogenesis. I. Modification of hydroxyurea-induced teratogenesis by the antioxidant propyl gallate.
    DeSesso JM
    Teratology; 1981 Aug; 24(1):19-35. PubMed ID: 7302871
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Protection against cadmium-induced teratogenicity in vitro by glycine.
    Paniagua-Castro N; Escalona-Cardoso G; Madrigal-Bujaidar E; Martínez-Galero E; Chamorro-Cevallos G
    Toxicol In Vitro; 2008 Feb; 22(1):75-9. PubMed ID: 17904331
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A review of the contribution of whole embryo culture to the determination of hazard and risk in teratogenicity testing.
    Webster WS; Brown-Woodman PD; Ritchie HE
    Int J Dev Biol; 1997 Apr; 41(2):329-35. PubMed ID: 9184342
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The area under the concentration-time curve of all-trans-retinoic acid is the most suitable pharmacokinetic correlate to the embryotoxicity of this retinoid in the rat.
    Tzimas G; Thiel R; Chahoud I; Nau H
    Toxicol Appl Pharmacol; 1997 Apr; 143(2):436-44. PubMed ID: 9144460
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Teratogenesis of retinoic acid in rats: susceptible stages and suppression of retinoic acid-induced limb malformations by cycloheximide.
    Kistler A
    Teratology; 1981 Feb; 23(1):25-31. PubMed ID: 7245088
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.